Dynavax Technologies CORP Form 4 insider transactions
David Novack, President & COO of Dynavax Technologies, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
John Slebir, SVP General Counsel of Dynavax Technologies, reports the vesting of restricted stock units and subsequent tax withholding, along with shares acquired through the Employee Stock Purchase Plan.
Dynavax Technologies CEO Ryan Spencer reports the vesting of restricted stock units and subsequent tax withholding.
Kelly MacDonald, SVP and CFO of Dynavax Technologies, reports the vesting of restricted stock units and subsequent stock transactions.
Robert Janssen, SVP and CMO of Dynavax Technologies, reports the vesting of restricted stock units and subsequent tax withholding.
Justin Burgess, VP of Finance & CAO at Dynavax Technologies, reports the vesting of restricted stock units and subsequent tax withholding.
Director Lauren P Silvernail reports the acquisition of stock options and restricted stock units in Dynavax Technologies Corp.
Form 4: Dynavax Technologies Director Emilio Emini Acquires Stock Options and Restricted Stock Units
Director Emilio Emini acquired stock options and restricted stock units in Dynavax Technologies Corp on February 3, 2025.
Director Francis Cano of Dynavax Technologies Corp. acquired 3,615 shares of common stock at $11.93 per share on May 31, 2024.
Director Scott Dunseth Myers reports acquisition of restricted stock units and stock options, along with disposal of common stock.
Julia Marie Eastland, a director at Dynavax Technologies, recently acquired shares and stock options in the company.
Director Daniel L. Kisner reported acquiring 5,357 shares of common stock and disposing of 17,571 shares, while also acquiring 22,500 stock options in Dynavax Technologies Corp.
Director Brent MacGregor reports acquisition of restricted stock units and stock options in Dynavax Technologies.
Director Peter R. Paradiso reported the acquisition of 5,357 restricted stock units and 22,500 stock options, along with the disposal of 5,357 common stock shares.
Director Peggy V Phillips reports acquiring 5,357 shares of Dynavax Technologies and disposing of 43,804 shares, along with being granted options to purchase 22,500 shares.
Director Elaine Sun reports acquisition of restricted stock units and stock options in Dynavax Technologies Corp.
Director Francis Cano reports acquisition and disposal of Dynavax Technologies Corp common stock and stock options.
Justin Burgess, VP of Finance & CAO of Dynavax Technologies, reports the acquisition of 20,000 stock options.
Form 4: Dynavax Technologies Corp: Chief Accounting Officer Justin Burgess Reports Stock Transactions
Chief Accounting Officer Justin Burgess of Dynavax Technologies Corp. reports exercising stock options and selling shares on March 1, 2024.